Diagnostic performance of plasma high sensitive C-reactive protein in detecting three-vessel coronary artery disease: Modification by apolipoprotein E genotype

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue 8, 2008, Pages 714-719

  Mennander, Ari ^a   Kuukasjärvi, Pekka ^a   Laurikka, Jari ^a   Nikus, Kjell ^a   Karhunen, Pekka J ^b   Tarkka, Matti ^a   Lehtimäki, Terho ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

Angiography; Apolipoprotein genotype; Coronary artery disease; Coronary atherosclerosis; CRP

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN MODIFICATION; RECEIVER OPERATING CHARACTERISTIC;

ALLELES; APOLIPOPROTEINS E; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 57349185787     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510802172145     Document Type: Article

References (20)

1. Mazer SP, Rabbani LRE. Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immunoregulation and CRP. J Thromb Thrombolysis 2004;17:95-105.
2. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9.
3. Zwaka TP, Hombac V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages. Implications for atherosclerosis. Circulation 2001;103:1194-7.
4. Woollard KJ, Phillips DC, Griffiths HR. Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells. Clin Exp Immunol 2002;130:256-62.
5. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30.
6. März W, Scharnagl H, Hoffmann MM, Boehm BO, Winkelmann BR. The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). Eur Heart J 2004;25:2109-19.
7. Austin MA, Zhang C, Humphries SE, Chandler WL, Talmud PJ, Edwards KL, et al. Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans. Ann Hum Genet 2004;68:179-88.
8. Ilveskoski E, Perola M, Lehtimäki T, Laippala P, Savolainen V, Pajarinen J, et al. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men. An autopsy study. Circulation 1999;100:608-13.
9. Lehtimäki T, Hervonen A, Rontu R, Karhunen P, Jylhä M, Hurme M. Survival related to plasma C-reactive-protein in nonagenarians is modified by apolipoprotein E genotype. Clin Chem 2007;53:365-7.
10. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 guidelines update for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee to update the 1999 guidelines for coronary artery bypass graft surgery). Circulation 2004;110:340-437.
11. Judkins MP. Selective coronary arteriography. Radiology 1967;89:815.
12. Eda S, Kaufmann J, Roos W, Pohl S. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 1998;12:137-44.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
15. Kardia SLR, Haviland MB, Ferrell RE, Sing CF. The relationship between risk factor levels and presence of coronary artery calcification is dependent on Apolipoprotein E genotype. Arterioscler Thromb Vasc Biol 1999;19:427-35.
16. Chen Q, Reis SE, Kammerer CM, McNamara DM, Holubkov R, Sharaf BL, et al. APOE polymorphism and angiographic coronary artery disease severity in the Women's Ischemia Syndrome Evaluation (WISE) study. Atherosclerosis 2003;169:159-67.
17. Lahoz C, Schaefer EJ, Cupples A, Wilson PWF, Levy D, Osgood D, et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 2001;154:529-37.
18. Judson R, Brain C, Dain B, Windemuth A, Ruano G, Reed C. New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals. Atherosclerosis 2004;177:345-51.
19. Paul A, Ko KWS, Li L, Yechoor V, McCrory MA, Szalai AJ, et al. C-reactive protein accelerates the progression of atherosclerosis in Apolipoprotein E-deficient mice. Circulation 2004;109:647-55.
20. Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, et al. C-reactive protein in the arterial intima. Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000;20:2094-9.